GVHD


Also found in: Dictionary, Acronyms.
Related to GVHD: HLA

GVHD

Abbreviation for graft versus host disease.

GVHD

abbreviation for graft-versus-host disease.

GVHD

Graft-versus-host disease, see there.

GVHD

Abbreviation for graft-versus-host disease.

GVHD

Abbreviation for graft-versus-host disease.

GVHD

graft-versus-host-disease.
References in periodicals archive ?
This scenario stands in contrast to the situation where a patient has postinflammatory hyperpigmentation, for example, further along in the course of epidermal GVHD.
Skin biopsy was done in five patients with AD-like GVHD, eight patients with LP-like GVHD and eight healthy volunteers.
The research team, which included graduate students and scientists from City of Hope, Mayo Clinic, Fred Hutchinson Cancer Research Center and three Chinese medical schools, observed that temporary in vivo depletion of a specific type of donor T cells (CD4+) soon after infusion of donor stem cell transplants prevented GVHD while preserving strong graft-versus-leukemia (GVL) effects.
If approved, Incyte expects to commercialize ruxolitinib for GVHD in the US and under the terms of the existing collaboration and license agreement would be eligible to receive potential milestone payments and royalties on sales of ruxolitinib in GVHD by Novartis outside the US
3%, of which five patients died of organ failure, two patients died of uncontrolled GVHD and two died of uncontrolled bleeding.
Conditioning regimen included fludarabine and cyclophosphamide, and GVHD prophylaxis given was cyclosporine (3mg/Kg/day) and methotrexate (10mg/7mg/7mg/7mg) on days 1, 3, 6 and 11).
Grading of chronic GVHD uses both the number of organ systems involved as well as the level of disability caused by symptoms.
During follow-up, between 17% and 73% of patients developed chronic GVHD and 29%-67% developed acute GVHD.
Clinical information included time from transplant to biopsy, the original hematologic diagnosis, histologic evidence of GVHD in other organ systems (upper GI tract, skin, liver, etc), response before or after additional GVHD therapy, and follow-up from time of biopsy to the endpoint, defined as either resolution of symptoms, exacerbation of GVHD, or death.
How will the GVHD market landscape change within the 2013-2023 forecast period in the 6MM?